<DOC>
	<DOC>NCT00710580</DOC>
	<brief_summary>Compare the efficacy of ABT-874 versus etanercept in subjects with moderate to severe plaque psoriasis</brief_summary>
	<brief_title>Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Diagnosis of Psoriasis for 6 MO BSA 10% PASI 12 or above PGA 3 or above Previous exposure to either etanercept or ABT874</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>